Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors
2006

Improving Retroviral Vector Production with Histone Deacetylase Inhibitors

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): Jaalouk Diana E, Crosato Milena, Brodt Pnina, Galipeau Jacques

Primary Institution: McGill University

Hypothesis

The mechanism of transcriptional suppression in self-inactivating retroviral vectors involves the recruitment of histone deacetylases (HDACs).

Conclusion

Histone deacetylation is implicated in the mechanism of transcriptional suppression in self-inactivating retroviral vectors, and treatment with HDAC inhibitors can enhance vector production.

Supporting Evidence

  • Treatment with sodium butyrate resulted in a 106.3 ± 4.6-fold increase in titer.
  • Histone acetylation increased in treated producer cells.
  • The SINCMV retroviral producer had uniformly very low titers (~10,000 infectious retroparticles per ml).

Takeaway

Researchers found that using certain drugs can help make more of a special type of virus used in gene therapy, which can help treat diseases.

Methodology

The study involved designing a self-inactivating retroviral vector and testing the effects of histone deacetylase inhibitors on viral titer in packaging cells.

Limitations

The study primarily focused on a specific cell line and may not be generalizable to all retroviral vector systems.

Statistical Information

P-Value

P = 0.002

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1743-422X-3-27

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication